Tag: Psilera - Psychedelic Alpha

Introducing Pα+: learn more and subscribe today.

Read more about the article Psilera’s Award-Winning Co-Founders To Be Featured Speakers at Upcoming Industry Conferences Across the Country.

Psilera’s Award-Winning Co-Founders To Be Featured Speakers at Upcoming Industry Conferences Across the Country.

Post published:October 20, 2022
Post category:Press Release

Read more about the article Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Post published:September 14, 2022
Post category:Press Release

Read more about the article Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

Post published:August 10, 2022
Post category:Press Release

Read more about the article Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago

Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago

Post published:March 24, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.